NO20050599L - Fremgangsmate for a anrike og spore patologisk modifiserte prion-proteiner (PRPsc) - Google Patents

Fremgangsmate for a anrike og spore patologisk modifiserte prion-proteiner (PRPsc)

Info

Publication number
NO20050599L
NO20050599L NO20050599A NO20050599A NO20050599L NO 20050599 L NO20050599 L NO 20050599L NO 20050599 A NO20050599 A NO 20050599A NO 20050599 A NO20050599 A NO 20050599A NO 20050599 L NO20050599 L NO 20050599L
Authority
NO
Norway
Prior art keywords
prpsc
enriching
tracking
methods
prion proteins
Prior art date
Application number
NO20050599A
Other languages
English (en)
Norwegian (no)
Inventor
Claudia Engemann
Katja Hoeschler
Jorg Lehmann
Jorg Gabert
Ulrike Krummrei
Original Assignee
Scleussner Chathrin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scleussner Chathrin filed Critical Scleussner Chathrin
Publication of NO20050599L publication Critical patent/NO20050599L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/968—Plasmin, i.e. fibrinolysin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
NO20050599A 2002-07-04 2005-02-03 Fremgangsmate for a anrike og spore patologisk modifiserte prion-proteiner (PRPsc) NO20050599L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10230141A DE10230141B4 (de) 2002-07-04 2002-07-04 Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc)
PCT/DE2003/002249 WO2004005920A2 (de) 2002-07-04 2003-07-04 Verfahren zur anreicherung und zum nachweis von pathologisch veränderten prion-proteinen (prpsc)

Publications (1)

Publication Number Publication Date
NO20050599L true NO20050599L (no) 2005-04-01

Family

ID=30009806

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050599A NO20050599L (no) 2002-07-04 2005-02-03 Fremgangsmate for a anrike og spore patologisk modifiserte prion-proteiner (PRPsc)

Country Status (12)

Country Link
US (1) US20060094071A1 (de)
EP (1) EP1520178A2 (de)
JP (1) JP2005531775A (de)
CN (1) CN1666106A (de)
AU (1) AU2003250773A1 (de)
BR (1) BR0312282A (de)
CA (1) CA2489151A1 (de)
DE (2) DE10230141B4 (de)
EA (1) EA200500125A1 (de)
NO (1) NO20050599L (de)
PL (1) PL375358A1 (de)
WO (1) WO2004005920A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040072236A1 (en) * 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof
NZ580256A (en) 2003-08-13 2011-07-29 Novartis Vaccines & Diagnostic Prion-specific peptide reagents comprising the sequence KKRPKPGG
US20060035242A1 (en) * 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
US20090130774A1 (en) * 2005-01-13 2009-05-21 David Peretz Elisa assays using prion-specific peptide reagents
WO2006076497A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Osplation of pathogenic prions
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
EP1931695B1 (de) * 2005-09-09 2013-04-10 Novartis AG Prionspezifische Peptoidreagentien
WO2007123345A1 (en) * 2006-04-21 2007-11-01 Peoplebio, Inc. Method for differentially detecting multimeric form from monomeric form of multimer-forming polypeptides through three-dimensional interactions
JP2010510175A (ja) * 2006-11-10 2010-04-02 ディメリックス・バイオサイエンス・ピーティーワイ・リミテッド 甲状腺刺激ホルモン放出ホルモン受容体−オレキシン受容体のヘテロダイマー／オリゴマー
EP2282753A1 (de) * 2008-04-30 2011-02-16 Novartis AG Assay für pathogene conformer
CN103336124B (zh) * 2012-12-11 2015-07-15 武汉工业学院 一种检测朊病毒蛋白(PrPSC)的方法和试剂盒

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE177754T1 (de) * 1991-12-03 1999-04-15 Proteus Molecular Design Fragmente von prion proteinen.
US5948763A (en) * 1995-06-07 1999-09-07 New York University Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
WO1997021728A1 (en) * 1995-12-12 1997-06-19 Karolinska Innovations Ab PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b)
FI982481A0 (fi) * 1998-11-17 1998-11-17 Wallac Oy Immunomääritys nautaeläinten tarttuvan spongiomuotoisen aivotaudin määrittämiseksi
US6150172A (en) * 1999-01-08 2000-11-21 The United States Of America As Represented By The Secretary Of Agriculture Method and kit for extracting prion protein
GB9917725D0 (en) * 1999-07-28 1999-09-29 Medical Res Council Peptides
GB9917724D0 (en) * 1999-07-28 1999-09-29 Medical Res Council Peptides
WO2002000713A1 (en) * 2000-06-26 2002-01-03 Universität Zürich Prion-binding activity in serum and plasma determined as plasminogen and fibrinogen
EP1216258A1 (de) * 1999-09-28 2002-06-26 Universität Zürich Faktoren mit prionen bindender aktivität im serum und plasma sowie mittel zur bestimmung von übertragbaren spongiformen encephalopathien
AU781044B2 (en) * 1999-11-05 2005-05-05 Axonyx, Inc. Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological precursor thereof
US20020115717A1 (en) * 2000-07-25 2002-08-22 Francine Gervais Amyloid targeting imaging agents and uses thereof
DE10120562C2 (de) * 2001-04-26 2003-04-10 Horst Messer Verfahren zur Diagnose von übertragbaren spongiformen Enzephalopathien

Also Published As

Publication number Publication date
EA200500125A1 (ru) 2005-08-25
CA2489151A1 (en) 2004-01-15
DE10393421D2 (de) 2005-06-09
DE10230141B4 (de) 2004-07-15
DE10230141A1 (de) 2004-02-05
BR0312282A (pt) 2005-04-12
PL375358A1 (en) 2005-11-28
AU2003250773A1 (en) 2004-01-23
CN1666106A (zh) 2005-09-07
WO2004005920A3 (de) 2004-04-29
WO2004005920A2 (de) 2004-01-15
EP1520178A2 (de) 2005-04-06
US20060094071A1 (en) 2006-05-04
JP2005531775A (ja) 2005-10-20

Similar Documents

Publication Publication Date Title
PT1644484E (pt) Células autólogas de indução de auto-tolerância de origem monocítica e sua utilização em preparações farmacêuticas
BR122018016045B8 (pt) proteína variante otimizada
NO20032062D0 (no) Arrangement og fremgangsmåte for lokalisering av lydkilde
BR0314814A (pt) Variantes otimizadas de fc e métodos para sua geração
ATE424560T1 (de) Marker für neuromyelitis optica
NO20050599L (no) Fremgangsmate for a anrike og spore patologisk modifiserte prion-proteiner (PRPsc)
CY1108221T1 (el) Μεθοδος για την αναπαραγωγη πλευρομουτιλινων
MY133625A (en) Peptide deformylase inhibitors
GB0208041D0 (en) Method of culturing animal cells
DK0914605T3 (da) Molekylemodel for VLA-4-inhibitorer
NO20025738D0 (no) Metode
ATE425962T1 (de) Peptid-deformylase-hemmer
ATE548037T1 (de) Peptid-deformylase-hemmer
ATE312077T1 (de) Peptiddeformylase-hemmer
GB0220199D0 (en) Mutant protein and refolding method
ATE514683T1 (de) Peptid-deformylase-hemmer
TW200504218A (en) Methods for preventing gluconoylation of proteins
RU95108064A (ru) Способ развития музыкального слуха и устройство для его осуществления
ATE433953T1 (de) Peptiddeformylaseinhibitoren
DE60304065D1 (de) Optimierte proteinsynthese
ATE392480T1 (de) Verfahren zur vorhersage der expressionseffizienz in zellfreien expressionssystemen
ATE309984T1 (de) Peptid-deformylase-hemmer
SI1461360T1 (sl) Konjugati, ki obsegajo protitelo, specifično za domeno ED-B fibronektina, in njihova uporaba za detekcijo in zdravljenje tumorjev
SE0202245D0 (sv) Novel sequence information and methods for its use in diagnosis and therapy VI.2
SE0201955D0 (sv) Novel sequence information and methods for its use in diagnosis and therapy V